1 |
1-deoxynojirimycin |
Duvoglustat |
1件: D09605 D09605 💬 |
GAA 1件: GAA 💬 |
Galactose metabolism 4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 1件: 256 💬 |
2 |
1-deoxynojirimycin hydrochloride |
Duvoglustat |
1件: D09605 D09605 💬 |
GAA 1件: GAA 💬 |
Galactose metabolism 4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 1件: 256 💬 |
3 |
A-glucosidasi acida umana ricombinante coniugata con multiple copie di bis-mannosio-6- fosfato-tetra-mannosio glicano sintetico (neogaa) |
Avalglucosidase alfa |
1件: D11744 D11744 💬 |
GAA 1件: GAA 💬 |
Galactose metabolism 4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 1件: 256 💬 |
4 |
Aav2/8lsphgaa |
- |
- |
- |
- |
256 1件: 256 💬 |
5 |
Acetaminophen |
Acetaminophen |
1件: D00217 D00217 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
011 14件: 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬 |
6 |
Albuterol |
Salbutamol |
1件: D02147 D02147 💬 |
ADRB2 1件: ADRB2 💬 |
Adrenergic signaling in cardiomyocytes 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
012 8件: 12, 13, 86, 89, 113, 231, 256, 299 💬 |
7 |
Aldurazyme (laronidase) |
Laronidase |
1件: D04670 D04670 💬 |
IDUA 1件: IDUA 💬 |
Glycosaminoglycan degradation 3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways |
019 2件: 19, 256 💬 |
8 |
Alglucosidase alfa |
Alglucosidase alfa |
1件: D03207 D03207 💬 |
GAA 1件: GAA 💬 |
Galactose metabolism 4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 1件: 256 💬 |
9 |
Alglucosidase alfa (genetical recombination) |
Alglucosidase alfa |
1件: D03207 D03207 💬 |
GAA 1件: GAA 💬 |
Galactose metabolism 4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 1件: 256 💬 |
10 |
Alglucosidase alfa (gz419829) |
Alglucosidase alfa |
1件: D03207 D03207 💬 |
GAA 1件: GAA 💬 |
Galactose metabolism 4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 1件: 256 💬 |
11 |
Alglucosidase alfa (myozyme) |
Alglucosidase alfa |
1件: D03207 D03207 💬 |
GAA 1件: GAA 💬 |
Galactose metabolism 4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 1件: 256 💬 |
12 |
Alglucosidase alfa (recombinant human acid alpha-glucosidase [rhgaa]) |
Alglucosidase alfa |
1件: D03207 D03207 💬 |
GAA 1件: GAA 💬 |
Galactose metabolism 4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 1件: 256 💬 |
13 |
Alglucosidase alfa gz419829 |
Alglucosidase alfa |
1件: D03207 D03207 💬 |
GAA 1件: GAA 💬 |
Galactose metabolism 4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 1件: 256 💬 |
14 |
Alglucosidase alpha |
- |
- |
- |
- |
256 1件: 256 💬 |
15 |
Alpha-glucosidase |
Alglucosidase alfa |
1件: D03207 D03207 💬 |
GAA 1件: GAA 💬 |
Galactose metabolism 4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 1件: 256 💬 |
16 |
At2220 |
AT2220 |
- |
- |
- |
256 1件: 256 💬 |
17 |
At2221 |
- |
- |
- |
- |
256 1件: 256 💬 |
18 |
At2221 65 mg formulated capsules |
- |
- |
- |
- |
256 1件: 256 💬 |
19 |
At845 |
- |
- |
- |
- |
256 1件: 256 💬 |
20 |
Atb200 |
- |
- |
- |
- |
256 1件: 256 💬 |
21 |
Avalglucosidase alfa |
Avalglucosidase alfa |
1件: D11744 D11744 💬 |
GAA 1件: GAA 💬 |
Galactose metabolism 4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 1件: 256 💬 |
22 |
Avalglucosidase alfa (neogaa) |
Avalglucosidase alfa |
1件: D11744 D11744 💬 |
GAA 1件: GAA 💬 |
Galactose metabolism 4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 1件: 256 💬 |
23 |
Avalglucosidase alfa gz402666 |
Avalglucosidase alfa |
1件: D11744 D11744 💬 |
GAA 1件: GAA 💬 |
Galactose metabolism 4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 1件: 256 💬 |
24 |
Avalglucosidase alfa(gz402666) |
Avalglucosidase alfa |
1件: D11744 D11744 💬 |
GAA 1件: GAA 💬 |
Galactose metabolism 4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 1件: 256 💬 |
25 |
Beta-hydroxybuturate esters |
- |
- |
- |
- |
256 1件: 256 💬 |
26 |
Bmn 701 |
- |
- |
- |
- |
256 1件: 256 💬 |
27 |
Bortezomib |
Bortezomib |
1件: D03150 D03150 💬 |
PSMB5 1件: PSMB5 💬 |
Alzheimer disease 8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia |
011 15件: 11, 13, 26, 28, 46, 49, 51, 61, 63, 66, 228, 256, 283, 288, 331 💬 |
28 |
Cipaglucosidase alfa |
- |
- |
- |
- |
256 1件: 256 💬 |
29 |
Clenbuterol |
Clenbuterol |
1件: D07713 D07713 💬 |
ADRB2 1件: ADRB2 💬 |
Adrenergic signaling in cardiomyocytes 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
001 4件: 1 , 2 , 6 , 256 💬 |
30 |
Cyclophosphamide |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
011 44件: 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 222, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬 |
31 |
Cyclophosphamide monohydrate |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
013 4件: 13, 60, 96, 256 💬 |
32 |
Deoxynojirimycin |
Duvoglustat |
1件: D09605 D09605 💬 |
GAA 1件: GAA 💬 |
Galactose metabolism 4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 1件: 256 💬 |
33 |
Deprakine |
- |
- |
- |
- |
256 1件: 256 💬 |
34 |
Diphenhydramine |
Diphenhydramine |
6件: D00300 D00300, D00669 D00669, D02419 D02419, D03285 D03285, D03360 D03360, D03854 D03854 💬 |
HRH1 1件: HRH1 💬 |
Calcium signaling pathway 3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
011 8件: 11, 49, 51, 70, 86, 96, 222, 256 💬 |
35 |
Duvoglustat |
Duvoglustat |
1件: D09605 D09605 💬 |
GAA 1件: GAA 💬 |
Galactose metabolism 4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 1件: 256 💬 |
36 |
Duvoglustat hcl |
Duvoglustat |
1件: D09605 D09605 💬 |
GAA 1件: GAA 💬 |
Galactose metabolism 4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 1件: 256 💬 |
37 |
Duvoglustat hydrochloride |
Duvoglustat |
1件: D09605 D09605 💬 |
GAA 1件: GAA 💬 |
Galactose metabolism 4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 1件: 256 💬 |
38 |
Enzyme replacement agent |
- |
- |
- |
- |
256 1件: 256 💬 |
39 |
Epilim |
- |
- |
- |
- |
256 1件: 256 💬 |
40 |
Epilim chrono 200 controlled released tablets |
- |
- |
- |
- |
256 1件: 256 💬 |
41 |
Epilim chrono 300 controlled released tablets |
- |
- |
- |
- |
256 1件: 256 💬 |
42 |
Epilim chrono 500 controlled released tablets |
- |
- |
- |
- |
256 1件: 256 💬 |
43 |
Filgrastim |
Filgrastim |
1件: D03235 D03235 💬 |
CSF3R 1件: CSF3R 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 27件: 2 , 6 , 13, 25, 26, 28, 34, 35, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬 |
44 |
Genetic: recombinant adeno-associated virus acid alpha-glucosidase |
Alglucosidase alfa |
1件: D03207 D03207 💬 |
GAA 1件: GAA 💬 |
Galactose metabolism 4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 1件: 256 💬 |
45 |
Gilt-rhgaa |
- |
- |
- |
- |
256 1件: 256 💬 |
46 |
Glucosidase alfa |
- |
- |
- |
- |
256 1件: 256 💬 |
47 |
Glycosade |
- |
- |
- |
- |
065 3件: 65, 256, 257 💬 |
48 |
Gz402666 |
- |
- |
- |
- |
256 1件: 256 💬 |
49 |
Intravenous immune globulin |
- |
- |
- |
- |
256 1件: 256 💬 |
50 |
Ketocal 4:1 liquid nutricia (intervention) |
- |
- |
- |
- |
256 1件: 256 💬 |
51 |
Laronidase |
Laronidase |
1件: D04670 D04670 💬 |
IDUA 1件: IDUA 💬 |
Glycosaminoglycan degradation 3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways |
019 2件: 19, 256 💬 |
52 |
Lidocaine |
Lidocaine |
3件: D00358 D00358, D02086 D02086, D08127 D08127 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
006 10件: 6 , 13, 34, 46, 51, 86, 168, 226, 231, 256 💬 |
53 |
Lmx 4 topical cream |
- |
- |
- |
- |
256 1件: 256 💬 |
54 |
Low carbohydrate ketogenic diet |
- |
- |
- |
- |
256 1件: 256 💬 |
55 |
Lumizyme |
- |
- |
- |
- |
256 1件: 256 💬 |
56 |
Lumizyme® |
- |
- |
- |
- |
256 1件: 256 💬 |
57 |
Mannose |
Mannose |
- |
- |
- |
013 2件: 13, 256 💬 |
58 |
Methotrexate |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
011 35件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬 |
59 |
Methotrexate sodium |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 2件: 46, 256 💬 |
60 |
Miglustat |
Miglustat |
1件: D05032 D05032 💬 |
UGCG 1件: UGCG 💬 |
Metabolic pathways 2件: Metabolic pathways, Sphingolipid metabolism |
019 3件: 19, 256, 299 💬 |
61 |
Miglustat (at2221) |
Miglustat |
1件: D05032 D05032 💬 |
UGCG 1件: UGCG 💬 |
Metabolic pathways 2件: Metabolic pathways, Sphingolipid metabolism |
256 1件: 256 💬 |
62 |
Myozyme |
- |
- |
- |
- |
256 1件: 256 💬 |
63 |
Myozyme 50 mg powder for concentrate for solution for infusion |
- |
- |
- |
- |
256 1件: 256 💬 |
64 |
Myozyme® |
- |
- |
- |
- |
256 1件: 256 💬 |
65 |
Myozyme® (alglucosidase alfa) |
Alglucosidase alfa |
1件: D03207 D03207 💬 |
GAA 1件: GAA 💬 |
Galactose metabolism 4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 1件: 256 💬 |
66 |
N.a. |
- |
- |
- |
- |
003 10件: 3 , 6 , 8 , 13, 46, 96, 97, 240, 256, 271 💬 |
67 |
Neo-gaa |
- |
- |
- |
- |
256 1件: 256 💬 |
68 |
Neogaa |
Avalglucosidase alfa |
1件: D11744 D11744 💬 |
GAA 1件: GAA 💬 |
Galactose metabolism 4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 1件: 256 💬 |
69 |
Neogaa or avalglucosidase alfa |
Avalglucosidase alfa |
1件: D11744 D11744 💬 |
GAA 1件: GAA 💬 |
Galactose metabolism 4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 1件: 256 💬 |
70 |
Other: no treatment |
- |
- |
- |
- |
053 2件: 53, 256 💬 |
71 |
Other: rmst |
- |
- |
- |
- |
256 1件: 256 💬 |
72 |
Other: saline |
- |
- |
- |
- |
002 8件: 2 , 6 , 46, 97, 98, 256, 274, 301 💬 |
73 |
Phosphate |
Phosphate ion |
- |
- |
- |
002 30件: 2 , 3 , 11, 12, 13, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 256, 276, 283, 284, 285, 286, 299 💬 |
74 |
Plecebo |
- |
- |
- |
- |
256 1件: 256 💬 |
75 |
Pyridostigmine |
Pyridostigmine |
1件: D00487 D00487 💬 |
ACHE 1件: ACHE 💬 |
Cholinergic synapse 2件: Cholinergic synapse, Glycerophospholipid metabolism |
003 4件: 3 , 6 , 11, 256 💬 |
76 |
Pyridostigmine bromide |
Pyridostigmine |
1件: D00487 D00487 💬 |
ACHE 1件: ACHE 💬 |
Cholinergic synapse 2件: Cholinergic synapse, Glycerophospholipid metabolism |
003 3件: 3 , 6 , 256 💬 |
77 |
Raav1-cmv-gaa (study agent) administration |
- |
- |
- |
- |
256 1件: 256 💬 |
78 |
Rapamycin |
Sirolimus |
1件: D00753 D00753 💬 |
MTOR 1件: MTOR 💬 |
AMPK signaling pathway 50件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
002 18件: 2 , 15, 34, 35, 46, 49, 51, 60, 61, 67, 86, 89, 96, 157, 158, 256, 278, 279 💬 |
79 |
Recombinant human ?-glucosidase conjugated with synthetic bismannose-6-phosphate-man6 glycan |
Phosphate ion |
- |
- |
- |
256 1件: 256 💬 |
80 |
Recombinant human a-glucosidase conjugated with multiple copies of synthetic bis-mannose-6-phosphate-tetra-mannose glycan (neogaa) |
Avalglucosidase alfa |
1件: D11744 D11744 💬 |
GAA 1件: GAA 💬 |
Galactose metabolism 4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 1件: 256 💬 |
81 |
Recombinant human a-glucosidase conjugated with multiple copies of synthetic bis-mannose-6-phosphate-tetra-mannose glycan avalglucosidase alfa (neogaa) |
Avalglucosidase alfa |
1件: D11744 D11744 💬 |
GAA 1件: GAA 💬 |
Galactose metabolism 4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 1件: 256 💬 |
82 |
Recombinant human acid alfa-glucosidase |
- |
- |
- |
- |
256 1件: 256 💬 |
83 |
Recombinant human acid alfa-glucosidase (atb200) |
- |
- |
- |
- |
256 1件: 256 💬 |
84 |
Recombinant human acid alfa-glucosidase (rhgaa) |
- |
- |
- |
- |
256 1件: 256 💬 |
85 |
Recombinant human acid alpha-glucosidase (rhgaa) |
Alglucosidase alfa |
1件: D03207 D03207 💬 |
GAA 1件: GAA 💬 |
Galactose metabolism 4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 1件: 256 💬 |
86 |
Ren001 |
ReN001 |
- |
- |
- |
256 1件: 256 💬 |
87 |
Reveglucosidase alfa |
- |
- |
- |
- |
256 1件: 256 💬 |
88 |
Reveglucosidase alpha |
- |
- |
- |
- |
256 1件: 256 💬 |
89 |
Rhgaa |
- |
- |
- |
- |
256 1件: 256 💬 |
90 |
Rhgaa, acid alpha glucosidase |
- |
- |
- |
- |
256 1件: 256 💬 |
91 |
Rituxan |
- |
- |
- |
- |
046 4件: 46, 60, 256, 288 💬 |
92 |
Rituximab |
Rituximab |
1件: D02994 D02994 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
011 47件: 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬 |
93 |
Salbutamol |
Salbutamol |
1件: D02147 D02147 💬 |
ADRB2 1件: ADRB2 💬 |
Adrenergic signaling in cardiomyocytes 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
003 9件: 3 , 11, 49, 85, 86, 111, 228, 256, 299 💬 |
94 |
Sodium valproate |
Valproic acid |
1件: D00399 D00399 💬 |
ABAT 7件: ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 |
Alanine, aspartate and glutamate metabolism 17件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
002 4件: 2 , 90, 102, 256 💬 |
95 |
Spk-3006 |
- |
- |
- |
- |
256 1件: 256 💬 |
96 |
Ss-hydroxybuturate esters |
- |
- |
- |
- |
256 1件: 256 💬 |
97 |
Triheptanoin |
Triheptanoin |
1件: D11465 D11465 💬 |
- |
- |
002 9件: 2 , 8 , 149, 156, 248, 256, 257, 317, 324 💬 |
98 |
Ux007 |
- |
- |
- |
- |
008 4件: 8 , 248, 256, 257 💬 |
99 |
Val-1221 |
- |
- |
- |
- |
256 1件: 256 💬 |
100 |
Valproate |
Valproic acid |
1件: D00399 D00399 💬 |
ABAT 7件: ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 |
Alanine, aspartate and glutamate metabolism 17件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
002 6件: 2 , 3 , 90, 102, 233, 256 💬 |
101 |
Valproic acid |
Valproic acid |
1件: D00399 D00399 💬 |
ABAT 7件: ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 |
Alanine, aspartate and glutamate metabolism 17件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
003 10件: 3 , 5 , 26, 34, 65, 89, 90, 222, 256, 331 💬 |
102 |
Zavesca |
- |
- |
- |
- |
019 3件: 19, 256, 299 💬 |
103 |
Zavesca® prescription |
- |
- |
- |
- |
256 1件: 256 💬 |